Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117373) titled 'The effect of plateau hypoxia on the population pharmacokinetics of dagliflozin in the treatment of type 2 diabetes mellitus' on Jan. 23.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The 940th Hospital of Joint Logistic Support Force
Condition:
Type 2 diabetes mellitus
Intervention:
Plateau group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-12-11
Target Sample Size: Plateau group:30;Plain group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=285135
Published by HT Digital...